No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Marengo Doses First Patient in STARt-002 Clinical Trial Evaluating First-in-Class Dual T Cell Agonist, Invikafusp Alfa in Combination With TROP2-directed ADC Trodelvy in Metastatic Breast Cancer
Market Chatter: Singapore's HDB Resale Prices Jump 9.3% in April
Malaysia Property Sector's Long-Term Outlook Remains Positive -- Market Talk
Roche's Ventana Trop2 W Breakthrough Device Designation From US FDA
CK Life Sciences Reports Promising Preclinical Results for TROP2 Cancer Vaccines
Malaysian REITs Likely to See Strong Earnings Growth in 1Q -- Market Talk
